Mental Retardation
Disease Details
Family Health Simplified
- Description
- Mental retardation, now more commonly referred to as intellectual disability, is a condition characterized by significant limitations in both intellectual functioning and adaptive behavior, which covers many everyday social and practical skills.
- Type
-
Mental retardation, more commonly referred to as intellectual disability, can result from numerous genetic causes. Types of genetic transmission include:
1. Autosomal Dominant
2. Autosomal Recessive
3. X-Linked Dominant
4. X-Linked Recessive
5. Mitochondrial Inheritance
Each type of genetic transmission corresponds to different specific conditions associated with intellectual disability. Examples include Down syndrome (commonly due to trisomy 21), Fragile X Syndrome (X-linked), and Rett syndrome (X-linked dominant). - Signs And Symptoms
-
Intellectual disability (ID) becomes apparent during childhood and involves deficits in mental abilities, social skills, and core activities of daily living (ADLs) when compared to same-aged peers. There often are no physical signs of mild forms of ID, although there may be characteristic physical traits when it is associated with a genetic disorder (e.g., Down syndrome).The level of impairment ranges in severity for each person. Some of the early signs can include:
Delays in reaching, or failure to achieve milestones in motor skills development (sitting, crawling, walking)
Slowness learning to talk, or continued difficulties with speech and language skills after starting to talk
Difficulty with self-help and self-care skills (e.g., getting dressed, washing, and feeding themselves)
Poor planning or problem-solving abilities
Behavioral and social problems
Failure to grow intellectually, or continued infant childlike behavior
Problems keeping up in school
Failure to adapt or adjust to new situations
Difficulty understanding and following social rulesIn early childhood, mild ID (IQ 50–69) may not be obvious or identified until children begin school. Even when poor academic performance is recognized, it may take expert assessment to distinguish mild intellectual disability from specific learning disability or emotional/behavioral disorders. People with mild ID are capable of learning reading and mathematics skills to approximately the level of a typical child aged nine to twelve. They can learn self-care and practical skills, such as cooking or using the local mass transit system. As individuals with intellectual disabilities reach adulthood, many learn to live independently and maintain gainful employment. About 85% of persons with ID are likely to have mild ID.
Moderate ID (IQ 35–49) is nearly always apparent within the first years of life. Speech delays are particularly common signs of moderate ID. People with moderate intellectual disabilities need considerable support in school, at home, and in the community in order to fully participate. While their academic potential is limited, they can learn simple health and safety skills and to participate in simple activities. As adults, they may live with their parents, in a supportive group home, or even semi-independently with significant supportive services to help them, for example, manage their finances. As adults, they may work in a sheltered workshop. About 10% of persons with ID are likely to have moderate ID.
People with Severe ID (IQ 20–34), accounting for 3.5% of persons with ID, or Profound ID (IQ 19 or below), accounting for 1.5% of persons with ID, need more intensive support and supervision for their entire lives. They may learn some ADLs, but an intellectual disability is considered severe or profound when individuals are unable to independently care for themselves without ongoing significant assistance from a caregiver throughout adulthood. Individuals with profound ID are completely dependent on others for all ADLs and to maintain their physical health and safety. They may be able to learn to participate in some of these activities to a limited degree. - Prognosis
- The prognosis for individuals with intellectual disability (previously referred to as mental retardation) varies widely based on the severity of the condition and the presence of any accompanying medical, psychological, or social issues. With appropriate support, including education, therapeutic services, and community integration, many individuals can lead fulfilling lives. Early intervention and specialized programs can significantly improve cognitive, social, and adaptive skills, enhancing overall quality of life.
- Onset
- Mental retardation, now more commonly referred to as intellectual disability, typically has an onset during the developmental period, specifically before the age of 18. The condition is characterized by significant limitations in both intellectual functioning and in adaptive behavior, which covers many everyday social and practical skills.
- Prevalence
- The prevalence of intellectual disability (previously referred to as mental retardation) is generally estimated to be about 1-3% of the population. This can vary depending on diagnostic criteria and population studied.
- Epidemiology
- Intellectual disability affects about 2–3% of the general population. 75–90% of the affected people have mild intellectual disability. Non-syndromic or idiopathic ID accounts for 30–50% of cases. About a quarter of cases are caused by a genetic disorder. Cases of unknown cause affect about 95 million people as of 2013. It is more common in males and in low to middle income countries.
- Intractability
-
The term "mental retardation" is now considered outdated and offensive; it has been largely replaced by "intellectual disability." Intellectual disability is characterized by significant limitations in both intellectual functioning and adaptive behavior, which covers a range of everyday social and practical skills.
In terms of intractability, intellectual disability is generally a lifelong condition, meaning there is currently no cure. However, with appropriate support, education, and interventions, individuals with intellectual disabilities can develop skills and improve their quality of life. Early intervention and tailored strategies can lead to better outcomes. - Disease Severity
- The term "mental retardation" is now considered outdated and offensive. The preferred term is "intellectual disability." Intellectual disability severity is categorized into four levels: mild, moderate, severe, and profound. Severity is based on adaptive functioning and intellectual capabilities, typically measured by standardized testing and observation. Each level reflects the degree of support and intervention required in daily life and functioning.
- Healthcare Professionals
- Disease Ontology ID - DOID:1059
- Pathophysiology
- The pathophysiology of intellectual disability, historically referred to as mental retardation, involves a complex interplay of genetic, environmental, and neurological factors that disrupt normal brain development and function. Genetic causes can include chromosomal abnormalities (e.g., Down syndrome), single-gene disorders (e.g., Fragile X syndrome), and metabolic disorders (e.g., phenylketonuria). Environmental factors may involve prenatal exposure to toxins, infections, or malnutrition. Additionally, complications during birth or early childhood, such as hypoxic-ischemic encephalopathy or traumatic brain injury, can also contribute. These factors can impair neural connectivity, synaptic plasticity, and neurodevelopmental processes critical for cognitive functioning.
- Carrier Status
- Carrier status for mental retardation, also known as intellectual disability, depends on its underlying cause, which can be genetic or non-genetic. Genetic causes include conditions like Down syndrome, Fragile X syndrome, and others that may involve specific mutations or chromosomal abnormalities. Carrier status can typically be determined through genetic testing, especially in conditions where a single gene mutation is responsible. Non-genetic causes, such as environmental factors during pregnancy, do not involve carrier status.
- Mechanism
-
Mental retardation, now more commonly referred to as intellectual disability, involves below-average cognitive functioning and a lack of skills necessary for daily living. Its causes can be diverse, including genetic, environmental, and multifactorial factors.
**Mechanism:**
Intellectual disability is typically characterized by significant limitations both in intellectual functioning (e.g., reasoning, learning, problem-solving) and in adaptive behavior, which covers a range of everyday social and practical skills.
**Molecular Mechanisms:**
Several molecular mechanisms can contribute to intellectual disability:
1. **Genetic Mutations:**
- **Single-Gene Disorders:** Mutations in specific genes can lead to intellectual disability. Examples include Fragile X syndrome (caused by mutations in the FMR1 gene) and Rett syndrome (associated with mutations in the MECP2 gene).
- **Chromosomal Abnormalities:** Trisomy 21 (Down syndrome) is a common chromosomal disorder resulting from an extra copy of chromosome 21.
2. **Epigenetic Changes:**
- Abnormal DNA methylation and histone modification patterns can disrupt gene expression, contributing to intellectual disability. For example, Prader-Willi syndrome and Angelman syndrome involve epigenetic changes on chromosome 15.
3. **Metabolic Disorders:**
- Certain inborn errors of metabolism, like phenylketonuria (PKU), can lead to intellectual disability if not managed. These often involve the accumulation of toxic substances or deficits in essential metabolic products due to enzymatic defects.
4. **Neurotransmitter Dysfunction:**
- Alterations in neurotransmitter systems can also lead to intellectual disability. For example, disorders affecting the synthesis or breakdown of brain neurotransmitters, like GABA or dopamine, can impair neural communication.
5. **Synaptic Dysfunction:**
- Abnormalities in synapse formation and function are recurrent themes in intellectual disability. Mutations affecting synaptic proteins, such as neuroligins or neurexins, can disrupt synaptic connectivity and plasticity.
Understanding these diverse molecular mechanisms helps in diagnosing and developing potential therapeutic strategies for intellectual disability. - Treatment
-
The term "mental retardation" is considered outdated and offensive. The preferred terms are "intellectual disability" or "intellectual developmental disorder." Treatment typically involves a combination of therapeutic, educational, and social supports, personalized to the individual's needs.
1. **Educational Interventions**: Special education programs tailored to the individual's level of functioning and learning pace.
2. **Behavioral Therapies**: Strategies to improve adaptive skills, reduce problematic behaviors, and teach new skills.
3. **Medical Treatment**: Addressing any underlying medical conditions or co-occurring disorders (e.g., seizures, mental health issues).
4. **Vocational Training**: Preparation for employment through skill-building and job placement services.
5. **Family Support**: Counseling and training for family members to help them understand and support their loved one.
6. **Social Support**: Facilitating social integration and community involvement.
7. **Assistive Technology**: Devices and software to aid learning and communication.
It's essential for treatment to be comprehensive and multidisciplinary, involving healthcare providers, educators, therapists, and family members. - Compassionate Use Treatment
-
Compassionate use treatment, also known as expanded access, allows patients with serious or life-threatening conditions to access investigational drugs, biologics, or medical devices that have not yet been approved by regulatory authorities. For mental retardation (now commonly referred to as intellectual disability), compassionate use treatments could potentially include experimental therapies aimed at managing associated symptoms or underlying conditions.
Off-label treatments are those that use medications approved for other conditions but not specifically for intellectual disability. Physicians might prescribe medications off-label to manage symptoms such as aggression, anxiety, or attention deficits that often accompany intellectual disabilities.
Experimental treatments could include a range of approaches under investigation in clinical trials. These might involve innovative drug therapies, gene therapies, or other advanced medical interventions targeting the underlying genetic or neurological causes of intellectual disability.
It is important to note that the effectiveness and safety of these treatments would vary, and they should be considered only under the guidance of qualified healthcare professionals. - Lifestyle Recommendations
-
For individuals with intellectual disability (previously referred to as mental retardation), the following lifestyle recommendations can help improve quality of life:
1. **Structured Routine:** Maintaining a predictable and structured daily routine can provide a sense of security and help with managing tasks and responsibilities.
2. **Physical Activity:** Regular physical activity can enhance overall health, improve mood, and increase social interactions. Tailored exercise programs can be beneficial.
3. **Healthy Diet:** A balanced diet rich in fruits, vegetables, whole grains, and lean proteins can support physical health and cognitive function.
4. **Social Engagement:** Encouraging participation in social activities and community groups can foster social skills and reduce isolation.
5. **Educational Support:** Access to special education programs and resources tailored to individual needs can enhance learning and development.
6. **Skill Development:** Focus on developing life skills such as personal hygiene, cooking, and money management to promote independence.
7. **Regular Medical Care:** Routine check-ups and prompt treatment of health issues are essential for maintaining overall health.
8. **Therapeutic Interventions:** Engagement in occupational, speech, or physical therapy can address specific developmental delays and improve functional abilities.
9. **Family and Caregiver Support:** Providing education and support to family members and caregivers can ensure they are well-equipped to offer effective assistance and reduce caregiver stress.
10. **Safe Environment:** Ensuring a safe and supportive living environment is crucial for physical safety and emotional well-being.
Implementing these recommendations can help individuals with intellectual disabilities lead fulfilling and productive lives. - Medication
- Mental retardation, now more commonly referred to as intellectual disability, cannot be treated with medication as there is no cure for the condition itself. However, medications may be used to manage symptoms or co-occurring conditions such as attention-deficit/hyperactivity disorder (ADHD), anxiety, or depression. Treatment typically focuses on supportive therapies, educational interventions, and vocational training to help individuals achieve their full potential.
- Repurposable Drugs
- There are currently no widely recognized repurposable drugs specifically for treating mental retardation (now often referred to as intellectual disability) across a broad range of cases. Treatment and management typically focus on addressing the individual's specific needs and may include educational interventions, behavioral therapy, and addressing co-morbid conditions. Certain medications may be used to manage symptoms of associated disorders, such as ADHD or anxiety, but these are not direct treatments for intellectual disability itself.
- Metabolites
- There isn't a direct linkage between specific "metabolites" and the condition historically referred to as "mental retardation," which is now more appropriately termed "intellectual disability." Intellectual disability can arise from various genetic, environmental, and metabolic factors. However, some metabolic disorders such as phenylketonuria (PKU) and congenital hypothyroidism can lead to intellectual disability if not treated early. These conditions involve abnormal metabolite levels that can affect brain development and function. PKU, for example, involves elevated levels of phenylalanine, which can be harmful if not managed through diet.
- Nutraceuticals
-
There is limited evidence to support the use of nutraceuticals (dietary supplements thought to provide medical or health benefits) specifically for mental retardation, now more commonly referred to as intellectual disability (ID). Nutraceuticals such as vitamins, minerals, omega-3 fatty acids, and antioxidants have been studied for their potential benefits in supporting overall brain health and development. However, these should not replace conventional medical treatments and should be discussed with a healthcare provider.
Nanotechnology (nan) in the treatment of intellectual disability is an emerging field. Research is ongoing to explore how nanoparticles can be used to deliver drugs more effectively to the brain, potentially targeting specific pathways involved in cognitive function. However, this research is still in the experimental stages and is not yet widely implemented in clinical practice. - Peptides
- Peptides and nanotechnology (nan) are emerging areas of research in understanding and treating various conditions, including intellectual disability (previously referred to as mental retardation). Peptides, which are short chains of amino acids, can influence brain function and development. Researchers are exploring the role of specific peptides in cognitive functions and their potential therapeutic applications. Nanotechnology involves the manipulation of matter on an atomic or molecular scale and holds promise in targeted drug delivery systems, potentially improving the efficacy and precision of treatments for intellectual disability. However, these are still largely in the experimental research phase.